Status:
COMPLETED
Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?
Lead Sponsor:
Northwell Health
Conditions:
Latent Tuberculosis
HIV Infections
Eligibility:
All Genders
18-75 years
Brief Summary
HIV infection highly increases the risk of progression of latent tuberculosis (TB) to active disease that therapy is recommended for all PPD-positive, HIV-infected patients, regardless of age. Sensiti...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- adult individuals with confirmed HIV infection
- Exclusion Criteria:
- Patients who are on INH treatment
- Patients who have a positive PPD test within 1 year of study enrollment
- Individuals with blistering or ulcerating skin disorder
- Pregnant women
- Patients who were given blood transfusion within 6 weeks prior to enrollment
Exclusion
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00763295
Start Date
May 1 2008
End Date
January 1 2010
Last Update
October 26 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Staten Island University Hospital
Staten Island, New York, United States, 10305